Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 121–135 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4657 CAST Gene Peeling Skin with Leukonychia, Acral Punctate Keratoses, Cheilitis, and Knuckle Pads Genetic Test This test analyzes the CAST gene for mutations associated with hereditary peeling skin syndrome.	Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAST gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Individuals with characteristic clinical features of hereditary peeling skin syndrome", "Confirmed family history of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 83519-7 ICD-10: Q82.8 Clinical summary This test analyzes the CAST gene for mutations associated with hereditary peeling skin syndrome.
TEST-5254 CAV3 Gene Distal Myopathy (Tateyama Type) Genetic Test This test identifies pathogenic variants in the CAV3 gene associated with distal myopathy, Tateyama type.	Peripheral whole blood (EDTA) or extracted DNA or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAV3 gene", "Coding region analysis"] Parameters [] Preparation ["Provide detailed clinical history", "Undergo pre-test genetic counselling", "No dietary or medication restrictions"] Indications ["Suspected distal myopathy, Tateyama type", "Family history of similar symptoms", "Confirmation of genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants in the CAV3 gene associated with distal myopathy, Tateyama type.
TEST-2482 CBL Gene Genetic Test for Noonan Syndrome‑like Disorder with or without Juvenile Myelomonocytic Leukemia This test evaluates the entire coding region and splice sites of the CBL gene for germline mutations.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the CBL gene", "Coding region and splice sites of the CBL gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of Noonan syndrome-like disorder", "Family history of Noonan syndrome-like disorder or JMML", "Evaluation of predisposition to JMML"] Measurement technique Confirm with laboratory Codes LOINC: 89539-1 ICD-10: Q87.19 Clinical summary This test evaluates the entire coding region and splice sites of the CBL gene for germline mutations.
TEST-3228 CBLIF Gene Intrinsic Factor Deficiency Genetic Test This genetic test identifies pathogenic variants in the CBLIF gene associated with intrinsic factor deficiency and potential pernicious anemia.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBLIF gene sequence", "Pathogenic variants in CBLIF"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected hereditary intrinsic factor deficiency", "Confirmation of genetic cause for B12 deficiency", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 55231-3 ICD-10: D51.0 Clinical summary This genetic test identifies pathogenic variants in the CBLIF gene associated with intrinsic factor deficiency and potential pernicious anemia.
TEST-4001 CBS Gene Homocystinuria due to Cystathionine Beta‑Synthase Deficiency Genetic Test This genetic test identifies disease-causing variants in the CBS gene, confirming a diagnosis of classic homocystinuria.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBS gene variants", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Personal or family history of unexplained thromboembolic events", "Early-onset stroke", "Myocardial infarction before age 50", "Deep vein thrombosis", "Pulmonary embolism", "Known consanguinity with homocystinuria"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E72.11 Clinical summary This genetic test identifies disease-causing variants in the CBS gene, confirming a diagnosis of classic homocystinuria.
TEST-3865 CD2AP Gene Sequencing (Focal Segmental Glomerulosclerosis Type 3) DNA Test This test evaluates the CD2AP gene for pathogenic variants associated with autosomal dominant Focal Segmental Glomerulosclerosis Type 3 (FSGS3).	Whole blood, extracted DNA, or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CD2AP gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session mandatory"] Indications ["Diagnosis of suspected FSGS Type 3", "Family screening for FSGS Type 3", "Personalized nephrology management"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: N04.1 Clinical summary This test evaluates the CD2AP gene for pathogenic variants associated with autosomal dominant Focal Segmental Glomerulosclerosis Type 3 (FSGS3).
TEST-3569 CD3G Gene Cone-Rod Dystrophy Type 17 DNA Test (NGS) This test detects pathogenic or likely pathogenic variants in the CD3G gene associated with cone-rod dystrophy type 17.	Peripheral Blood (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD3G gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected cone-rod dystrophy type 17", "Family history of inherited retinal dystrophy", "Need for genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81290-1 ICD-10: H35.54 Clinical summary This test detects pathogenic or likely pathogenic variants in the CD3G gene associated with cone-rod dystrophy type 17.
TEST-3802 CD46 Gene (Atypical Hemolytic Uremic Syndrome Type 2) Susceptibility Genetic Test This genetic test identifies pathogenic variants in the CD46 gene associated with atypical hemolytic uremic syndrome type 2.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD46 gene pathogenic variants", "Loss-of-function mutations"] Parameters [] Preparation [] Indications ["Personal or family history of atypical hemolytic uremic syndrome", "Early-onset renal failure", "Recurrent episodes", "Documented complement pathway abnormality", "Asymptomatic first-degree relatives of a proband with a confirmed CD46 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 81269-9 ICD-10: D59.3 Clinical summary This genetic test identifies pathogenic variants in the CD46 gene associated with atypical hemolytic uremic syndrome type 2.
TEST-4299 CDKL5 Gene Analysis for Early Infantile Epileptic Encephalopathy Type 2 (NGS) Test This test detects pathogenic variants in the CDKL5 gene associated with Early Infantile Epileptic Encephalopathy Type 2 (EIEE2).	Peripheral whole blood (EDTA tube) or FTA card / DNA	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKL5 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 2 (EIEE2)", "CDKL5 deficiency disorder"] Measurement technique Confirm with laboratory Codes LOINC: 97515-4 ICD-10: G40.4, G40.819, Z13.71 Clinical summary This test detects pathogenic variants in the CDKL5 gene associated with Early Infantile Epileptic Encephalopathy Type 2 (EIEE2).
TEST-2139 CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test This test sequences the CDKN1C gene to detect mutations associated with Beckwith-Wiedemann syndrome.	Peripheral Whole Blood (EDTA) or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN1C gene mutations", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any ongoing medications"] Indications ["Suspected Beckwith-Wiedemann syndrome based on clinical features", "Family history of Beckwith-Wiedemann syndrome", "Cancer risk stratification in individuals with BWS features"] Measurement technique Confirm with laboratory Codes LOINC: 94233-2 ICD-10: Q87.3 Clinical summary This test sequences the CDKN1C gene to detect mutations associated with Beckwith-Wiedemann syndrome.
TEST-2025 CDKN2A Gene Familial Melanoma and Neural System Tumor Syndrome Genetic Test (NGS) This genetic test evaluates the CDKN2A gene for mutations associated with increased risk of familial melanoma and neural system tumors.	Whole Blood (Peripheral), Saliva, or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the CDKN2A gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Individuals with a strong family history of melanoma", "Individuals with multiple atypical nevi", "Individuals with a family history of neural system tumors"] Measurement technique Confirm with laboratory Codes LOINC: 21648-9 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CDKN2A gene for mutations associated with increased risk of familial melanoma and neural system tumors.
TEST-1734 CEBPA Full Gene Mutation Analysis Test This test identifies somatic mutations in the CEBPA gene, which are critical prognostic markers in acute myeloid leukaemia (AML).	Peripheral Blood	5–6 working days from sample receipt	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in the CEBPA gene", "Biallelic or monoallelic mutations"] Parameters [] Preparation ["No fasting or special preparation required", "Bring original doctor’s prescription", "Bring valid Emirates ID"] Indications ["Risk stratification in acute myeloid leukaemia (AML)", "Prognosis in AML", "Classification of AML subtypes", "Guiding treatment intensity"] Measurement technique Confirm with laboratory Codes LOINC: 101543-4 ICD-10: C92.00, D46.9, Z15.09 Clinical summary This test identifies somatic mutations in the CEBPA gene, which are critical prognostic markers in acute myeloid leukaemia (AML).
TEST-3675 CentoIEM Genetic Test This test evaluates over 1,200 genes for variants associated with inherited neurological and inborn-error-of-metabolism disorders using Next Generation Sequencing.	Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic variants in over 1,200 genes", "Inherited neurological disorders", "Inborn errors of metabolism"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected inherited neurological disorder", "Suspected inborn error of metabolism", "Familial risk assessment", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94474-4 ICD-10: Z13.7 Clinical summary This test evaluates over 1,200 genes for variants associated with inherited neurological and inborn-error-of-metabolism disorders using Next Generation Sequencing.
TEST-2342 CEP152 Gene Seckel Syndrome Type 5 Genetic Test This test evaluates the CEP152 gene for pathogenic variants associated with Seckel syndrome type 5.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEP152 gene sequence", "Point mutations", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Suspected Seckel syndrome type 5", "Evaluation of primordial dwarfism"] Measurement technique Confirm with laboratory Codes LOINC: 104207-2 ICD-10: Q87.1 Clinical summary This test evaluates the CEP152 gene for pathogenic variants associated with Seckel syndrome type 5.
TEST-3954 CEP290 Gene Bardet-Biedl Syndrome Type 14 Genetic Test This genetic test identifies pathogenic variants in the CEP290 gene associated with Bardet-Biedl syndrome.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CEP290 gene exons and intron boundaries"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Confirmation of clinical diagnosis of Bardet-Biedl syndrome", "Carrier screening", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants in the CEP290 gene associated with Bardet-Biedl syndrome.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.